CXL Ophthalmics
0 followers
‌
CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally. Their EpiSmart approach is a transformative cross-linking system designed to treat keratoconus without disrupting the epithelium, allowing for a rapid... Read more
Industries
+1
Employees
Links
Org chart
Mike Webb
Chief Executive Officer & Board Member
Mike Webb
Collapse
Edward Parsons
Chief Operating Officer
Kevin E. Daly, RAC
SVP, Device Development & Regulatory Affairs
